DE3762621D1 - Oxabicycloheptan-derivate, pharmazeutische zusammensetzung und verwendung. - Google Patents

Oxabicycloheptan-derivate, pharmazeutische zusammensetzung und verwendung.

Info

Publication number
DE3762621D1
DE3762621D1 DE8787102795T DE3762621T DE3762621D1 DE 3762621 D1 DE3762621 D1 DE 3762621D1 DE 8787102795 T DE8787102795 T DE 8787102795T DE 3762621 T DE3762621 T DE 3762621T DE 3762621 D1 DE3762621 D1 DE 3762621D1
Authority
DE
Germany
Prior art keywords
group
sup
defined above
pharmaceutically acceptable
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787102795T
Other languages
English (en)
Inventor
Toshio Tatsuoka
Kenji Suzuki
Kayoko Imao
Fumio Satoh
Seiji Miyano
Kunihiro Sumoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Ltd
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of DE3762621D1 publication Critical patent/DE3762621D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
DE8787102795T 1986-02-27 1987-02-27 Oxabicycloheptan-derivate, pharmazeutische zusammensetzung und verwendung. Expired - Lifetime DE3762621D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61042732A JPH0723367B2 (ja) 1986-02-27 1986-02-27 オキサビシクロヘプタン誘導体

Publications (1)

Publication Number Publication Date
DE3762621D1 true DE3762621D1 (de) 1990-06-13

Family

ID=12644212

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787102795T Expired - Lifetime DE3762621D1 (de) 1986-02-27 1987-02-27 Oxabicycloheptan-derivate, pharmazeutische zusammensetzung und verwendung.

Country Status (8)

Country Link
US (1) US4713453A (de)
EP (1) EP0238883B1 (de)
JP (1) JPH0723367B2 (de)
AT (1) ATE52506T1 (de)
CA (1) CA1300138C (de)
DE (1) DE3762621D1 (de)
ES (1) ES2036183T3 (de)
GR (2) GR3000693T3 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3089040B2 (ja) * 1990-06-06 2000-09-18 サントリー株式会社 脳神経変性性疾患治療剤
US5401850A (en) * 1990-06-06 1995-03-28 Suntory Limited Cyclopropachromen derivatives
JP3054207B2 (ja) * 1990-06-06 2000-06-19 サントリー株式会社 シクロプロパクロメン誘導体
JP3993651B2 (ja) * 1994-10-21 2007-10-17 アスビオファーマ株式会社 シクロプロパクロメンカルボン酸誘導体
KR20070092309A (ko) * 2004-12-28 2007-09-12 아스비오파마 가부시키가이샤 탄소-감소된 알도오스 화합물의 제조 방법
IT1400964B1 (it) * 2010-06-15 2013-07-05 Dipharma Francis Srl Procedimento per la preparazione di derivati pteridinici
CA2977256C (en) * 2015-02-19 2023-08-08 John S. Kovach Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3468897A (en) * 1966-10-05 1969-09-23 Pierre Fournari Certain 6-amino-2-(aryl or heteroaryl)-4-chromanone-hydrazones and derivatives
JPS5829782A (ja) * 1981-08-12 1983-02-22 Nippon Zoki Pharmaceut Co Ltd 新規複素環化合物、その製法及び該化合物を含有する医薬組成物

Also Published As

Publication number Publication date
EP0238883A1 (de) 1987-09-30
GR900300046T1 (en) 1991-07-31
GR3000693T3 (en) 1991-09-27
US4713453A (en) 1987-12-15
ES2036183T3 (es) 1993-05-16
JPH0723367B2 (ja) 1995-03-15
EP0238883B1 (de) 1990-05-09
JPS62198676A (ja) 1987-09-02
ATE52506T1 (de) 1990-05-15
CA1300138C (en) 1992-05-05

Similar Documents

Publication Publication Date Title
DE3788145D1 (de) Piperidinderivate, diese enthaltende pharmazeutische Zusammensetzungen und ihre Verwendung.
PT81814B (pt) Processo para a preparacao de derivados de naftaleno
IE801162L (en) Pharmaceutical compositions
NO855204L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylcyklobutylalkylaminer.
JPS54154766A (en) Novel imidazole derivative*its manufacture and medicine containing said derivative and having antiiinflammatory and antiiallergic activity
ATE52506T1 (de) Oxabicycloheptan-derivate, pharmazeutische zusammensetzung und verwendung.
KR940003953A (ko) 1. 4-벤조디옥산 유도체
DE3363553D1 (en) Substituted alpha-(ethyl)-alpha-(phenyl)-(omega-(dialkylamino)-alkoxy)-benzyl alcohols, their acid addition salts and quaternary salts, process for their preparation, as well as medicines containing these compounds
MX9405111A (es) Nuevos derivados de (1-fenil-1-heterociclil)metanol y(1-fenil-1-heterociclil-metilamina).
CA2118425A1 (en) Benzothiazolesulfonamide derivative, Method for Preparing the Same, and Use Thereof
ATE18761T1 (de) Carbamoyloxybenzhydrol-derivate, ihre herstellung und ihre pharmazeutische zusammensetzungen.
MY106235A (en) New 2 - carbonyl substituted n, n'' -di (trimethoxybenzoyl) piperazines, process for preparing the same and therapeutical compounds containing them.
SE8603589D0 (sv) Metylendioxifenantren- och stilbenderivat
NO862494D0 (no) Fremgangsmaate for fremstilling av nye aromatiske forbindelser.
EP0373591A3 (de) Polyhydroxybenzyloxypropanolamine
HUT53089A (en) Process for producing cyclic guanidine derivatives of calcium-antagonistic activity and pharmaceutical compositions containing them
PT97885A (pt) Processo para a preparacao de derivados da {(1-aril-2-pirrolidinil)-metil-piperazina e de composicoes farmaceuticas que os contem
KR870006898A (ko) 신장염 치료제
DE3884878T2 (de) Uricosuretische Zusammensetzung.
KR910011258A (ko) 녹내장의 치료방법
GEP19980890B (en) Derivatives of N1-(1,2-Cis-halogeno¬-cyclopropyl) Substituted Pyridonecarbonic Acid

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee